A Phase 1, First-in-Human, Dose-Escalation Study of MGD024, a CD123 x CD3 Bispecific Dart® Molecule, in Patients with Relapsed or Refractory CD123-Positive (+) Hematologic Malignancies
| العنوان: | A Phase 1, First-in-Human, Dose-Escalation Study of MGD024, a CD123 x CD3 Bispecific Dart® Molecule, in Patients with Relapsed or Refractory CD123-Positive (+) Hematologic Malignancies |
|---|---|
| المؤلفون: | Eric S. Winer, Michael Maris, Manish R. Sharma, Patrick Kaminker, Enxu Zhao, Ashley Ward, Andrew L. Sochacki |
| المصدر: | Blood. 140:11753-11754 |
| بيانات النشر: | American Society of Hematology, 2022. |
| سنة النشر: | 2022 |
| مصطلحات موضوعية: | Immunology, Cell Biology, Hematology, Biochemistry |
| تدمد: | 1528-0020 0006-4971 |
| الوصول الحر: | https://explore.openaire.eu/search/publication?articleId=doi_________::7d69c9d630051cdc8866898bd3ebafa5Test https://doi.org/10.1182/blood-2022-159524Test |
| رقم الانضمام: | edsair.doi...........7d69c9d630051cdc8866898bd3ebafa5 |
| قاعدة البيانات: | OpenAIRE |
| تدمد: | 15280020 00064971 |
|---|